Predictors of Hyperkalemia Risk after Hypertension Control with Aldosterone Blockade according to the Presence or Absence of Chronic Kidney Disease

Publisher： Karger

E-ISSN： 1660-2110|128|3-4|381-386

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.128, Iss.3-4, 2015-0, pp. : 381-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analytical Review of the Evidence for Renoprotection by Renin-Angiotensin-Aldosterone System Blockade in Chronic Kidney Disease – A Call for Caution

By  

Nephron Clin Pract, Vol. 113, Iss. 2, 2009-07 ,pp. : c63-c70

Karger

Access to resources Recommend Favorite

Prevalence, Patterns of Treatment, and Control of Hypertension in Predialysis Patients with Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 120, Iss. 3, 2012-06 ,pp. : c147-c155

Karger

Access to resources Recommend Favorite

Glycemic control and cardiovascular disease in a high-risk chronic kidney disease population

By Singh Rachandeep   Nistala Ravi   McFarlane Samy I   Whaley-Connell Adam  

Therapy, Vol. 6, Iss. 4, 2009-07 ,pp. : 507-513

Future Medicine

Access to resources Recommend Favorite

Long-Term Angiotensin II Receptor Blockade Limits Hypertension, Aortic Dysfunction, and Structural Remodeling in a Rat Model of Chronic Kidney Disease

By  

Journal of Vascular Research, Vol. 53, Iss. 3-4, 2016-11 ,pp. : 216-229

Karger

Access to resources Recommend Favorite

Association of Hypo- and Hyperkalemia with Disease Progression and Mortality in Males with Chronic Kidney Disease: The Role of Race

By  

Nephron Clin Pract, Vol. 120, Iss. 1, 2011-12 ,pp. : c8-c16

Karger

Access to resources Recommend Favorite